We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Blood Biomarker Detected for Different Diseases

By LabMedica International staff writers
Posted on 05 Dec 2017
Print article
Image: A piezoelectrically actuated pipette system is used as an inexpensive means to detect biological molecules associated with specific diseases, infection or other medical conditions (Photo courtesy of Purdue University).
Image: A piezoelectrically actuated pipette system is used as an inexpensive means to detect biological molecules associated with specific diseases, infection or other medical conditions (Photo courtesy of Purdue University).
A method has been developed to identify biological markers in small amounts of blood that could be used to detect a myriad of diseases, infections and different medical conditions at early stages.

Microelectromechanical resonators, or small vibrating sensors, have been created that can detect these biomarkers using just a drop or two of blood. The plate-style resonant sensors allow sensitive, inexpensive detection of biomarkers that can signify disease, illness or trauma.

Biomedical engineers at Purdue University (Lafayette, IN, USA) developed a test that can detect minute amounts of proteins, including protein from glial cells, which surround neurons in the brain. The proteins are secreted in relatively high concentrations in cerebrospinal fluid of victims of traumatic brain injury. Prior studies have found that a small amount of fluid leaked through the blood-brain barrier and got into the bloodstream of victims.

The sensors use a piezoelectrically actuated resonant microsystem, which when driven by electricity can sense a change in mass. The sensitivity of the resonator increases as the resonant frequency increases, making high-frequency resonators excellent candidates for biomarker detection. The method also is much faster and less expensive than other types of medical tests. One of the first uses for the test could be the early detection of traumatic brain injury in athletes, particularly high school football and soccer players.

The effects of repeated head impacts on high school football players has shown changes in brain chemistry and metabolism even in players who have not been diagnosed with concussions. The test also is inexpensive so a high school football team could do several mass screenings a season and the test also could be used for the early detection of Alzheimer's disease and Parkinson's disease.

Eric A. Nauman, PhD, a professor in the School of Mechanical Engineering and a co-author of the study, said, “Essentially the idea is that if you can measure anything that passes through the blood-brain barrier from the brain into the blood, it's a problem because it should stay in the brain. There's a whole host of diseases and different conditions where, if you could find these things in small quantities early on and just make it part of a standard workup, you could decrease health-care costs greatly. The study was published on November 1, 2017, in the journal IEEE Sensors.

Related Links:
Purdue University

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Nutating Mixer
Enduro MiniMix

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.